Drug intelligence / Profile preview

phenyl salicylate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Phenyl salicylate is a small molecule drug classified as a 2-hydroxybenzoic acid phenyl ester. It acts as a mild analgesic and is used primarily for pain relief by releasing salicylate (the active component in aspirin). Its mechanism of action involves inhibition of cyclooxygenase (COX) enzymes—specifically prostaglandin G/H synthase 1 and 2—thereby reducing the formation of prostaglandins responsible for inflammation and pain. Phenyl salicylate is also found in combination products for urinary tract discomfort or infection-related symptoms. Beyond pharmaceuticals it has industrial uses in manufacturing polymers and other materials[1][3][5].

Brand names
HyophenPhosphasalUrelleUribelUrimar Reformulated Oct 2013Urin DSUstellUretron D/SUticapUtira-CUtrona-CUrised TabsMethylphenProsed DSAtroseptCystemms-VDarcalmaDarpazDolsedMhp-aMSP-Blu
Other names
2-hydroxybenzoic acid phenyl estersalol
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on phenyl salicylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phenyl salicylate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call